Women who suffer from polycystic ovary syndrome have a heightened chance of non-alcoholic fatty liver disease (NAFLD).
Two out of three women with Polycystic Ovary Syndrome (PCOS) suffer from non-alcoholic fatty liver disease (NAFLD), according to a new study that described this relationship for the first time. Experts from the American Association of Clinical Endocrinologists (AACE) will highlight the relationship between PCOS and NAFLD at a media teach-in, Tuesday, September 13, 2005, at the Washington (DC).
NAFLD is caused by fat accumulation in the liver that can lead to liver inflammation. Normally associated with obesity, NAFLD can be detected with an ultrasound. The prevalence of NAFLD was close to two-fold higher in obese women with PCOS than normal healthy women, and at least two to three-fold fold higher than healthy lean women in several prior ultrasonographic studies of NAFLD.
Women with PCOS usually have insulin resistance and metabolic disorder that is associated with serious medical disorders such as type 2 diabetes, hypertension, cardiovascular disease and stroke.